Daily non-political popular news in brief.

Cloning techniques produce FDA-approved antibiotic

11-27-2006 · EurekAlert!

The successful synthesis of an antibiotic in a non-native host has provided a team of researchers at the University of Illinois at Urbana-Champaign with the potential for developing new treatments for bacterial infections.

Keywords: cloning, techniques, produce, fda-approved, antibiotic, technique, fda, approved

« Previous | Next »

Similar news on "Cloning techniques produce FDA-approved antibiotic":

Nanofabrication method paves way for new optical devices
10-05-2007 · EurekAlert!
An innovative and inexpensive way of making nanomaterials on a large scale, developed at Northwestern University, has resulted in novel forms of advanced materials that pave the way for exceptional and unexpected optical properties. These include optical nanomaterials called "plasmonic metamaterials." The new fabrication technique, known as soft lithography, offers many significant advantages over existing techniques, including the ability to scale-up the manufacturing process to produce devices in large quantities.
Similar news · Read more »
New technique to 'see' and protect transplants successful in diabetic animal model
07-29-2007 · EurekAlert!
Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes. They developed a new technique encapsulates the insulin-producing cells in magnetic capsules, using an FDA-approved iron compound with an off-label use, which can be tracked by magnetic resonance imaging (MRI). The product, tested in swine and diabetic mice, also simultaneously avoids rejection by the immune system, likely a major reason for transplant failure.
Similar news · Read more »
UPMC performs first beating heart transplant procedure in the US
05-17-2007 · EurekAlert!
Protected by its own nutrients and blood supply, a beating heart supported by an investigational organ preservation device was successfully transplanted into a 47-year-old man with heart failure on Sunday, April 8. The surgery was performed at UPMC by Kenneth R. McCurry, M.D., assistant professor of surgery, division of cardiothoracic surgery at the University of Pittsburgh School of Medicine and director of cardiopulmonary transplantation at UPMC as part of an FDA approved investigational study.
Similar news · Read more »
FDA approves knee-injury device for humans
10-02-2007 · EurekAlert!
A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
Similar news · Read more »
New drug lets kids feel good in their skin
01-16-2008 · EurekAlert!
College student Maria Anichini no longer has to hide her skin under long sleeves and pants. Her skin and life have rebounded since she became part of a trial testing an injectable drug for children and adolescents with psoriasis, a common skin disease causing red scaly patches all over the body. Northwestern University researchers report the drug etanercept -- FDA approved for adults but never before tested in children for psoriasis-- dramatically reduced psoriasis flare-ups.
Similar news · Read more »
Jefferson scientist's patent dramatically improves
07-18-2007 · EurekAlert!
A basic scientist at Jefferson Medical College and the Kimmel Cancer Center at Jefferson, has shared a patent on what may someday be a ubiquitous tool in DNA analysis. He and a colleague at Johns Hopkins University, have developed a technique that makes a DNA separation technique called electrophoresis, five times faster and less expensive than is is possible. The discovery could have a range of applications, from forensics, to cloning, and also to bioterrorism.
Similar news · Read more »
Researchers complete first clinical trial of Apatone for cancer treatment
10-05-2007 · EurekAlert!
In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone. Demonstrating promising results, Apatone exploits a new strategy to selectively lower the level of compounds within tumor cells that assist in energy production and protect against chemotherapy. This non-toxic approach weakens and kills cancers in a novel way.
Similar news · Read more »
Turning green gunk to gold, anti-cancer gold
01-08-2007 · EurekAlert!
Combining synthetic chemistry techniques with a knowledge of the properties and actions of enzymes, scientists have been able to produce an exciting class of anti-cancer drugs originally isolated from blue-green algae.
Similar news · Read more »
Spot On: Printing flexible electronics one nanodot at a time
09-15-2007 · Science News Online
A new high-resolution printing technique could make flexible electronics such as plastic displays and solar cells easier to produce.
Similar news · Read more »
Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
05-21-2007 · EurekAlert!
New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile.
Similar news · Read more »